Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
Artoss Inc.
Study ID
NCT06256458
Status
Recruiting
Apply to this trial

Conditions

  • Fractures, Bone

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • NanoBone® Bone Graft — DEVICE
    The surgical technique used by the surgeon and the choice of the specific NanoBone product is or was determined solely by the surgeon and is independent of this observational study.

Study Details

This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.

Key Dates

Start date
Dec 1, 2023
Status verified
Feb 2025
Primary completion
Dec 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Radiographic evidence of fracture healing [ Time Frame: 2 weeks, 6 weeks, 3 months, 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
SSM Health St. Mary's HospitalMadisonWisconsin53715
Mitchell D Kuhl, DO
[email protected]
608-294-6464

Find similar trials in Madison, WI

By research site
SSM Health St. Mary's Hospital· Madison, WI

Related Studies